Immunofluorescent identification of antibodies specific for prostatic acid phosphatase.
Antisera demonstrated by precipitation and passive haemagglutination to possess antibodies specific for prostatic tissue-specific acid phosphatase have been employed to localize this isoenzyme in the prostate by indirect immunofluorescence. Antisera specific for prostatic acid phosphatase may permit the immunohistological localization of this enzyme, thereby serving as a biological marker for metastatic prostatic cancer, where histological and/or clinical staging of the primary tumour remain uncertain.